puc-header

Conformational Changes in the Cytoplasmic Region of KIR3DL1 Upon Interaction with SHP-2

47 Pages Posted: 28 Aug 2018 Publication Status: Published

See all articles by Hong Cheng

Hong Cheng

Temple University - Institute for Cancer Research

Vered Schwell

Temple University - Institute for Cancer Research

Brett R. Curtis

Temple University - Institute for Cancer Research

Ruzaliya Fazlieva

Temple University - Institute for Cancer Research

Heinrich Roder

Temple University - Institute for Cancer Research

Kerry S. Campbell

Temple University - Institute for Cancer Research

More...

Abstract

KIR3DL1 is an inhibitory killer cell Ig-like receptor (KIR) that negatively regulates natural killer (NK) cell cytotoxicity. The KIR3DL1 cytoplasmic region (3DL1-cyto) is disordered and can be dissected into three segments: (I) H340-V351; (II) M352-D371; and (III) P372-P423. NMR studies indicate that segment II adopts a transient loop-like conformation, and segments I and III can form dynamic helices that mediate binding to membranes, particularly surrounding the N-terminal (N) immunoreceptor tyrosine-based inhibitory motif (ITIM) in segment III, consistent with its role in signaling. Furthermore, individual SH2 domains of SHP-2 strongly engage with the unphosphorylated N-ITIM of 3DL1-cyto, while binding of the tandem SHP-2 SH2 domains to the bis-phosphorylated ITIMs results in more extensive conformational changes in segments I and III. The findings enhance our understanding of KIR function and how ITIMs in a target receptor operate in concert to engage the tandem SH2 domains of SHP-2.

Suggested Citation

Cheng, Hong and Schwell, Vered and Curtis, Brett R. and Fazlieva, Ruzaliya and Roder, Heinrich and Campbell, Kerry S., Conformational Changes in the Cytoplasmic Region of KIR3DL1 Upon Interaction with SHP-2 (2018). Available at SSRN: https://ssrn.com/abstract=3238695 or http://dx.doi.org/10.2139/ssrn.3238695
This version of the paper has not been formally peer reviewed.

Hong Cheng (Contact Author)

Temple University - Institute for Cancer Research ( email )

333 Cottman Ave
Philadelphia, PA 19107
United States

Vered Schwell

Temple University - Institute for Cancer Research

333 Cottman Ave
Philadelphia, PA 19107
United States

Brett R. Curtis

Temple University - Institute for Cancer Research

333 Cottman Ave
Philadelphia, PA 19107
United States

Ruzaliya Fazlieva

Temple University - Institute for Cancer Research

333 Cottman Ave
Philadelphia, PA 19107
United States

Heinrich Roder

Temple University - Institute for Cancer Research

333 Cottman Ave
Philadelphia, PA 19107
United States

Kerry S. Campbell

Temple University - Institute for Cancer Research

333 Cottman Ave
Philadelphia, PA 19107
United States

Click here to go to Cell.com

Paper statistics

Downloads
102
Abstract Views
724
PlumX Metrics